Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By

Top 2 search results for "Poteligeo" in Resources. To see all results and access other features, sign up for free.

... Another drug, Poteligeo (mogamulizumab), is a monoclonal antibody drug, meaning it can specifically recognize certain cell types. It is under investigation and has already been approved by the U.S. Food and Drug Administration for mycosis fungoides and Sezary syndrome. ...
Adult T-Cell Leukemia/Lymphoma (ATLL): Your Guide
... Another drug, Poteligeo (mogamulizumab), is a monoclonal antibody drug, meaning it can specifically recognize certain cell types. It is under investigation and has already been approved by the U.S. Food and Drug Administration for mycosis fungoides and Sezary syndrome. ...
... Monoclonal antibodies include: Mogamulizumab (Poteligeo) — Used to treat two rare forms of non-Hodgkin lymphoma (NHL): Sézary syndrome and mycosis fungoides Obinutuzumab (Gazyva) — Approved for some blood cancers, including follicular lymphoma and chronic lymphocytic leukemia Rituximab (Rituxan) — Approved for CD20-positive NHL and leukemia Tafasitamab-cxix ...
Immunotherapy for Lymphoma: 4 Points To Know
... Monoclonal antibodies include: Mogamulizumab (Poteligeo) — Used to treat two rare forms of non-Hodgkin lymphoma (NHL): Sézary syndrome and mycosis fungoides Obinutuzumab (Gazyva) — Approved for some blood cancers, including follicular lymphoma and chronic lymphocytic leukemia Rituximab (Rituxan) — Approved for CD20-positive NHL and leukemia Tafasitamab-cxix ...